Literature DB >> 21969816

Glioma cell migration on three-dimensional nanofiber scaffolds is regulated by substrate topography and abolished by inhibition of STAT3 signaling.

Paula A Agudelo-Garcia1, Jessica K De Jesus, Shante P Williams, Michal O Nowicki, Ennio Antonio Chiocca, Sandya Liyanarachchi, Pui-Kai Li, John J Lannutti, Jed K Johnson, Sean E Lawler, Mariano S Viapiano.   

Abstract

A hallmark of malignant gliomas is their ability to disperse through neural tissue, leading to long-term failure of all known therapies. Identifying new antimigratory targets could reduce glioma recurrence and improve therapeutic efficacy, but screens based on conventional migration assays are hampered by the limited ability of these assays to reproduce native cell motility. Here, we have analyzed the motility, gene expression, and sensitivity to migration inhibitors of glioma cells cultured on scaffolds formed by submicron-sized fibers (nanofibers) mimicking the neural topography. Glioma cells cultured on aligned nanofiber scaffolds reproduced the elongated morphology of cells migrating in white matter tissue and were highly sensitive to myosin II inhibition but only moderately affected by stress fiber disruption. In contrast, the same cells displayed a flat morphology and opposite sensitivity to myosin II and actin inhibition when cultured on conventional tissue culture polystyrene. Gene expression analysis indicated a correlation between migration on aligned nanofibers and increased STAT3 signaling, a known driver of glioma progression. Accordingly, cell migration out of glioblastoma-derived neurospheres and tumor explants was reduced by STAT3 inhibitors at subtoxic concentrations. Remarkably, these inhibitors were ineffective when tested at the same concentrations in a conventional two-dimensional migration assay. We conclude that migration of glioma cells is regulated by topographical cues that affect cell adhesion and gene expression. Cell migration analysis using nanofiber scaffolds could be used to reproduce native mechanisms of migration and to identify antimigratory strategies not disclosed by other in vitro models.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21969816      PMCID: PMC3182275          DOI: 10.1593/neo.11612

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  52 in total

1.  Change in pattern of relapse after antiangiogenic therapy in high-grade glioma.

Authors:  Ashwatha Narayana; Saroj D Kunnakkat; Praveen Medabalmi; John Golfinos; Erik Parker; Edmond Knopp; David Zagzag; Patricia Eagan; Deborah Gruber; Michael L Gruber
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-12-14       Impact factor: 7.038

Review 2.  Indentation versus tensile measurements of Young's modulus for soft biological tissues.

Authors:  Clayton T McKee; Julie A Last; Paul Russell; Christopher J Murphy
Journal:  Tissue Eng Part B Rev       Date:  2011-03-21       Impact factor: 6.389

3.  Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells.

Authors:  Christian Senft; Maike Priester; Margareth Polacin; Katrin Schröder; Volker Seifert; Donat Kögel; Jakob Weissenberger
Journal:  J Neurooncol       Date:  2010-06-30       Impact factor: 4.130

4.  Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3.

Authors:  Fan Yang; Christine Brown; Ralf Buettner; Michael Hedvat; Renate Starr; Anna Scuto; Anne Schroeder; Michael Jensen; Richard Jove
Journal:  Mol Cancer Ther       Date:  2010-04-06       Impact factor: 6.261

5.  Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells.

Authors:  Guang-Hui Li; Hong Wei; Sheng-Qing Lv; Hua Ji; Dong-Lin Wang
Journal:  Int J Oncol       Date:  2010-07       Impact factor: 5.650

6.  Cooperation between Stat3 and Akt signaling leads to prostate tumor development in transgenic mice.

Authors:  Jorge M Blando; Steve Carbajal; Erika Abel; Linda Beltran; Claudio Conti; Susan Fischer; John DiGiovanni
Journal:  Neoplasia       Date:  2011-03       Impact factor: 5.715

7.  The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas.

Authors:  Christian Senft; Margareth Polacin; Maike Priester; Volker Seifert; Donat Kögel; Jakob Weissenberger
Journal:  BMC Cancer       Date:  2010-09-14       Impact factor: 4.430

Review 8.  Molecular mechanisms of perineural invasion, a forgotten pathway of dissemination and metastasis.

Authors:  Federica Marchesi; Lorenzo Piemonti; Alberto Mantovani; Paola Allavena
Journal:  Cytokine Growth Factor Rev       Date:  2010-01-08       Impact factor: 7.638

9.  A distinctive role for focal adhesion proteins in three-dimensional cell motility.

Authors:  Stephanie I Fraley; Yunfeng Feng; Ranjini Krishnamurthy; Dong-Hwee Kim; Alfredo Celedon; Gregory D Longmore; Denis Wirtz
Journal:  Nat Cell Biol       Date:  2010-05-16       Impact factor: 28.824

10.  The transcriptional network for mesenchymal transformation of brain tumours.

Authors:  Maria Stella Carro; Wei Keat Lim; Mariano Javier Alvarez; Robert J Bollo; Xudong Zhao; Evan Y Snyder; Erik P Sulman; Sandrine L Anne; Fiona Doetsch; Howard Colman; Anna Lasorella; Ken Aldape; Andrea Califano; Antonio Iavarone
Journal:  Nature       Date:  2009-12-23       Impact factor: 49.962

View more
  38 in total

1.  The interconnectedness of cancer cell signaling.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

2.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

3.  Role of suspended fiber structural stiffness and curvature on single-cell migration, nucleus shape, and focal-adhesion-cluster length.

Authors:  Sean Meehan; Amrinder S Nain
Journal:  Biophys J       Date:  2014-12-02       Impact factor: 4.033

4.  Dissecting and rebuilding the glioblastoma microenvironment with engineered materials.

Authors:  Kayla J Wolf; Joseph Chen; Jason Coombes; Manish K Aghi; Sanjay Kumar
Journal:  Nat Rev Mater       Date:  2019-08-16       Impact factor: 66.308

Review 5.  Emerging Roles of Electrospun Nanofibers in Cancer Research.

Authors:  Shixuan Chen; Sunil Kumar Boda; Surinder K Batra; Xiaoran Li; Jingwei Xie
Journal:  Adv Healthc Mater       Date:  2017-12-06       Impact factor: 9.933

Review 6.  Toward 3D biomimetic models to understand the behavior of glioblastoma multiforme cells.

Authors:  Shreyas S Rao; John J Lannutti; Mariano S Viapiano; Atom Sarkar; Jessica O Winter
Journal:  Tissue Eng Part B Rev       Date:  2013-10-30       Impact factor: 6.389

7.  STAT3 silencing inhibits glioma single cell infiltration and tumor growth.

Authors:  Maike Priester; Ekaterini Copanaki; Vida Vafaizadeh; Sandra Hensel; Christian Bernreuther; Markus Glatzel; Volker Seifert; Bernd Groner; Donat Kögel; Jakob Weissenberger
Journal:  Neuro Oncol       Date:  2013-03-13       Impact factor: 12.300

8.  Rapid response oxygen-sensing nanofibers.

Authors:  Ruipeng Xue; Prajna Behera; Mariano S Viapiano; John J Lannutti
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-04-22       Impact factor: 7.328

9.  Aligned chitosan-polycaprolactone polyblend nanofibers promote the migration of glioblastoma cells.

Authors:  Forrest M Kievit; Ashleigh Cooper; Soumen Jana; Matthew C Leung; Kui Wang; Dennis Edmondson; David Wood; Jerry S H Lee; Richard G Ellenbogen; Miqin Zhang
Journal:  Adv Healthc Mater       Date:  2013-06-17       Impact factor: 9.933

10.  Mimicking white matter tract topography using core-shell electrospun nanofibers to examine migration of malignant brain tumors.

Authors:  Shreyas S Rao; Mark T Nelson; Ruipeng Xue; Jessica K DeJesus; Mariano S Viapiano; John J Lannutti; Atom Sarkar; Jessica O Winter
Journal:  Biomaterials       Date:  2013-04-16       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.